SCHEMBL24539749

SCHEMBL24539749

c1ccc(-c2ccccc2N(c2ccccc2)c2cccc(-c3cccc4c5ccc6oc7ccccc7c6c5c5ccccc5c34)c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.32
▸ CRHR1 P34998 1/20 0.31
▸ CDC14B O60729 1/20 0.31
▸ CDC14A Q9UNH5 1/20 0.31
▸ CDK4 P11802 1/20 0.30
▸ CCND1 P24385 1/20 0.30
▸ PLA2G10 O15496 1/20 0.30
▸ PLA2G2A P14555 1/20 0.30
▸ PLA2G4A P47712 1/20 0.30
▸ CYP1B1 Q16678 2/20 0.30
▸ GABRP O00591 1/20 0.30
▸ GABRD O14764 1/20 0.30
▸ NPC1 O15118 1/20 0.30
▸ CA12 O43570 1/20 0.30
▸ TNKS O95271 1/20 0.30
▸ CA1 P00915 1/20 0.30
▸ CA2 P00918 1/20 0.30
▸ TP53 P04637 1/20 0.30
▸ ABCB1 P08183 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24539761 0.98 PLA2G2A (0.33) ALOX5CRHR1PLA2G10PLA2G2APLA2G4A
SCHEMBL27011904 0.97 PLA2G2A (0.32) ALOX5PLA2G10PLA2G2APLA2G4A
SCHEMBL24539811 0.93 CDC14B (0.32) ALOX5CRHR1CDC14BCDC14APLA2G10
SCHEMBL24539813 0.92 PLA2G2A (0.32) CDC14BCDC14APLA2G10PLA2G2APLA2G4A
SCHEMBL24539756 0.92 ALOX5 (0.35) ALOX5CDC14BCDC14ACDK4CCND1
SCHEMBL24539759 0.92 CYP1A1 (0.31) CYP1B1ABCG2CYP1A1CYP1A2
SCHEMBL24539728 0.91 CYP1A1 (0.32) CDK4CCND1CYP1B1HPGDRAB9A
SCHEMBL24539744 0.91 ABCG2 (0.33) ALOX5CRHR1CYP1B1HPGDABCG2
SCHEMBL24539727 0.91 PLA2G2A (0.36) ALOX5CRHR1PLA2G10PLA2G2APLA2G4A
SCHEMBL27011991 0.91 PLA2G2A (0.34) PLA2G10PLA2G2APLA2G4ACYP1B1GABRP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240023432-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER LT MATERIALS CO., LTD. (KR) 2024-01-18 — — US disclosed
US-20240023432-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER LT MATERIALS CO., LTD. (KR) 2024-01-18 — — US disclosed
WO-2022131546-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER 엘티소재주식회사 2022-06-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240023432-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER CYP1B1, NOTUM, CYP4F11 ALOX5 238/4885CRHR1 3959/4885CDC14B 3680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback